Sort
40,608 grants matching “prostate cancer”
Genome targeting of liver cancer
$357,994Jianhua Luo · University Of Pittsburgh At Pittsburgh · R56 · FY2018 · CA
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2
$357,927Kavita Shah · Purdue University · R01 · FY2021 · CA
The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma
$357,918Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · CA
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2
$357,895Kavita Shah · Purdue University · R01 · FY2020 · CA
Pre-Clinical Evaluation Core
$357,891Mandi J. Lopez · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Engagement Optimization Unit
$357,891Jennifer W Mack · Broad Institute, Inc. · U2C · FY2023 · CA
Dissecting mechanisms of sensitivity to B7-H3 (CD276)-targeted therapeutics in prostate cancer (PC)
$357,891Justin H. Hwang · University Of Minnesota · R37 · FY2025 · CA
Decision Aids to Address Prostate Cancer Disparities in Minority Men
$357,881Jon C Tilburt · Mayo Clinic Rochester · R01 · FY2015 · MD
Cohort Study of Glucosamine and Chondroitin Supplement Use and Cancer Risk
$357,858Emily White · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
TRD 1 - Imaging Cancer Heterogeneity
$357,828Nathalie Yr Agar · Brigham And Women'S Hospital · P41 · FY2022 · EB
Artificial Intelligence Driven Automatic Treatment Planning of Stereotactic Radiosurgery for the Management of Multiple Brain Metastases
$357,794Zhen Tian · University Of Chicago · R37 · FY2025 · CA
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
$357,780Zheng-Rong Lu · Case Western Reserve University · R01 · FY2021 · CA
HEPARIN-BINDING EGF-LIKE FACTORS IN PROSTATE GROWTH
$357,778Michael R Freeman · Boston Children'S Hospital · R37 · FY2007 · DK
Role of FOXO1 Inactivation in Prostate Tumorigenesis
$357,750Haojie Huang · Mayo Clinic Rochester · R01 · FY2017 · CA
Role of FOXO1 Inactivation in Prostate Tumorigenesis
$357,750Haojie Huang · Mayo Clinic Rochester · R01 · FY2018 · CA
Role of FOXO1 Inactivation in Prostate Tumorigenesis
$357,750Haojie Huang · Mayo Clinic Rochester · R01 · FY2015 · CA
Role of FOXO1 Inactivation in Prostate Tumorigenesis
$357,750Haojie Huang · Mayo Clinic Rochester · R01 · FY2016 · CA
PROSTATE, LUNG, COLORECTAL &OVARIAN (PLCO) CANCER
$357,744Washington University · N01 · FY2000 · CN
Clinical Genomic Study
$357,727Kenneth J. Pienta · University Of Michigan At Ann Arbor · UM1 · FY2015 · HG
Genetically Engineered Viruses for Prostate Cancer Ther
$357,726Massachusetts General Hospital · R01 · FY2004 · CA
TARGETING DISTINCT IMMUNOSUPPRESSIVE MECHANISMS TO ACHIEVE SYNERGY FOR PROSTATE CANCER IMMUNOTHERAPY
$357,721The University Of Texas Southwestern Medical Center · · FY2014 · Department of Defense
Enhancing anti-neoplastic activity of metformin in prostate cancer
$357,717Xiaoqi Liu · Purdue University · R01 · FY2018 · CA
The contributions of sensory nerves to bone metastasis and associated bone pain
$357,702Yusuke Shiozawa · Wake Forest University Health Sciences · R01 · FY2024 · CA
Health Insurance and Disparities: More than Access
$357,694Cathy J. Bradley · University Of Colorado Denver · R01 · FY2025 · CA
Angiogenin-Induced RNA Cleavage in Cancer
$357,689Paul J. Anderson · Brigham And Women'S Hospital · R01 · FY2015 · CA